YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQVU1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,554
Award facts
- Contract value 100% obligated
- $7,554.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $7,554.48 delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, for YF-VAX 1 dose vials, with an ultimate completion date of March 30, 2026.
DMS Pharmaceutical Group is a woman-owned small business. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling. Place of performance is Park Ridge, Illinois. Pricing is firm fixed price.
Quick answers
Who was awarded contract SPE2DR26FQVU1?
SPE2DR26FQVU1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 9, 2026.
How much is contract SPE2DR26FQVU1 worth?
The government has obligated $7,554 on SPE2DR26FQVU1.
Is contract SPE2DR26FQVU1 an order under another contract?
Yes. SPE2DR26FQVU1 is a delivery order under SPE2DR25D9247, an indefinite delivery contract.
Was contract SPE2DR26FQVU1 competed?
The extent of competition for SPE2DR26FQVU1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award